SKF 83959 HYDROBROMIDE
SKF 83959 HYDROBROMIDE Basic information
- Product Name:
- SKF 83959 HYDROBROMIDE
- Synonyms:
-
- 6-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-1-(3-METHYLPHENYL)-1H-3-BENZAZEPINE-7,8-DIOL HYDROBROMIDE
- 6-CHLORO-7,8-DIHYDROXY-3-METHYL-1-(3-METHYLPHENYL)-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE
- SKF 83959 HYDROBROMIDE
- 6-Chloro-2,3,4,5-tetrahydro-3-methyl-1-(3-methylphenyl)-1H-3-benzazepine-7,8-diol
- 6-Chloro-7,8-dihydroxy-3-methyl-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide
- N-methyl-6-chloro-1-(3-methylphenyl)-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol
- 1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-3-methyl-1-(3-methylphenyl)-
- SKF 83959 hydrobromi
- CAS:
- 80751-85-5
- MF:
- C18H20ClNO2
- MW:
- 317.81
- Product Categories:
-
- Dopamine receptor
- Mol File:
- 80751-85-5.mol
SKF 83959 HYDROBROMIDE Chemical Properties
- storage temp.
- Store at RT
- solubility
- DMSO: 26 mg/mL, soluble
- form
- solid
- color
- white
Safety Information
- Safety Statements
- 22-24/25
- WGK Germany
- 3
MSDS
- Language:English Provider:SigmaAldrich
SKF 83959 HYDROBROMIDE Usage And Synthesis
Uses
SKF-83959 was used in dopamine signaling studies on eye blinking in monkeys and on phosphorylation of CaMKIIα in mice.
Definition
ChEBI: A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a 3-methylphenyl substituent at position 1, a methyl substituent at position 3, a chloro substituent at position 6 and two hydroxy substituents at positions 7 and 8. Dopamine D1-like receptor p rtial agonist (Ki values are 1.18, 7.56, 920 and 399 nM for rat D1, D5, D2 and D3 receptors respectively). May act as an antagonist in vivo, producing anti-Parkinsonian effects and antagonising the behavioral effects of cocaine.
Biological Activity
Dopamine D 1 -like receptor partial agonist (K i values are 1.18, 7.56, 920 and 399 nM for rat D 1 , D 5 , D 2 and D 3 receptors respectively). May act as an antagonist in vivo , producing antiparkinsonian effects and antagonizing the behavioral effects of cocaine.
in vivo
SKF83959 (0.5 and 1 mg/kg; i.p.; 1 hour) reverses the scopolamine-induced cognitive impairments in the passive avoidance task and Y-Maze test[1].
SKF83959 (1 mg/kg; i.p.; 30 minutes) induced memory enhancing effects are prevented by brain-derived neurotrophic factor system blockade[1].
SKF83959 has anti-amnesic activities and restores the scopolamine-decreased BDNF signaling pathway in the hippocampus in mice[1].
| Animal Model: | Male ICR male mice (8 weeks)[1] |
| Dosage: | 0.5 and 1 mg/kg |
| Administration: | I.p.; 1 hour |
| Result: | Reversed the scopolamine-induced cognitive impairments in the passive avoidance task and Y-Maze test. |
| Animal Model: | Male ICR male mice (8 weeks)[1] |
| Dosage: | 1 mg/kg |
| Administration: | I.p.; 30 minutes |
| Result: | The memory enhancing effects were prevented by BDNF system blockade. |
IC 50
D1 Receptor: 1.18 nM (Ki); Sigma 1 Receptor; D5 Receptor: 7.56 nM (Ki); D2 Receptor: 920 nM (Ki); D3 Receptor: 399 nM (Ki)
SKF 83959 HYDROBROMIDESupplier
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 888-539-0666
- info@emmx.com
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Tel
- 15921930842 15921930842
- yh-wang@univ-bio.com
- Tel
- 0513-66337626 18051384581
- sales@chemhifuture.com